|
|
|
Volumn 24, Issue 8, 2009, Pages 93-
|
|
FDA notifications. Raltegravir indication extended for treatment-naive patients.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 PYRROLIDONE DERIVATIVE;
INTEGRASE INHIBITOR;
RALTEGRAVIR;
ARTICLE;
DRUG APPROVAL;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
UNITED STATES;
DRUG APPROVAL;
DRUG LABELING;
HIV INFECTIONS;
HIV INTEGRASE INHIBITORS;
HUMANS;
PYRROLIDINONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 69249213757
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|